Articles tagged "Kidney transplantation"

2020 American Transplant Congress
Late Pneumocystis Jirovecii Pneumonia Often Misdiagnosed
M. Samaniego¹, R. Prashar¹, N. Khoury², A. Patel²
¹Transplant Institute, Henry Ford Health System, Detroit, MI, ²Transplant Institute, Henry Ford Health System, Ann Arbor, MI
*Purpose: Since 2/2018, we have identified 60 transplant recipients presenting with late PCR confirmed Pneumocystis jirovecii (PJP). Of this initial group, 17 kidney transplant recipients…
2020 American Transplant Congress
Optimal Transition for Transplant Recipients: A Model of Care in an Integrated Health Care System
S. Zheng¹, L. Pravoverov¹, A. Nazarova¹, D. Adey², N. B. Goes¹
¹The Permanente Medical Group, San Francisco, CA, ²Kidney and Transplantation Program, University of California San Francisco, San Francisco, CA
*Purpose: Transplantation is the treatment of choice for ESRD. While short-term outcomes have improved, long-term outcomes lag. Many factors may explain the long-term lag including…
2020 American Transplant Congress
Laparoscopic Donor Nephrectomy – Call for a Selective Radical Approach
A. Vijay¹, M. Cooper², J. Verbesey², P. Abrams², S. Yi², S. Ghasemian²
¹Transplant Surgery, University of North Carolina, Chapel Hill, NC, ²Transplant Surgery, Medstar Georgetown Transplant Institute, Washington, DC
*Purpose: Introduction: Retrieval of kidneys in obese donor with excessive peri-renal fat has been reported to be more technically challenging with increased incidence of surgical…
2020 American Transplant Congress
Lateral Flow Assay to Detect Soluble CD25 after Kidney Transplantation
L. K. Seiler, C. Blume, R. Jonczyk
Faculty of Natural Sciences, Institute of Technical Chemistry, Hannover, Germany
*Purpose: Kidney transplantations are one of the most common transplantations in the world; 80.696 kidneys were transplanted in 2017. Despite tremendous improvements in quality and…
2020 American Transplant Congress
Follow Up of Imlifidase (IdeS) Desensitized Kidney Transplant Recipients
S. C. Jordan¹, R. A. Montgomery², T. Lundgren³, C. Legendre⁴, N. Desai⁵, G. Eckerwall⁶, L. Laxmyr⁶, H. Olsson⁶, A. Runström⁶, Å. Schiött⁶, K. Sjöholm⁶, E. Sonesson⁶, L. Winstedt⁶, T. Lorant⁷, C. Kjellman⁶
¹Cedars Sinai Medical Center, Los Angeles, CA, ²NYU Langone Health Transplant Institute, New York, NY, ³Karolinska University Hospital, Stockholm, Sweden, ⁴Hospital Necker & Paris Descartes University, Paris, France, ⁵Johns Hopkins University, Baltimore, MD, ⁶Hansa Biopharma AB, Lund, Sweden, ⁷Uppsala University, Uppsala, Sweden
*Purpose: 46 highly sensitized patients received kidney transplants after desensitization with imlifidase (currently under investigation) across four Phase 2 clinical trials, and 6-month safety and…
2020 American Transplant Congress
KDPI-Based Kidney Discard Risk Assessment
S. Mehrotra¹, M. Barah², K. Bui³
¹IEMS Department, MEAS, Northwestern University, Evanston, IL, ²IEMS Department, Northwestern University, Evanston, IL, ³Department of Mathematics, University of California, Irvine, Irvine, CA
*Purpose: Despite the vital need, 3,553 (19%) deceased-donor kidneys were discarded in 2018 in the current US allocation system. The discard rate has remained at…
2020 American Transplant Congress
Incidence, Clinical Correlates and Outcomes of Pulmonary Hypertension after Kidney Transplantation: Analysis of Linked U.S. Registry and Medicare Billing Claims
K. Lentine¹, S. Costa², Y. Caliskan³, D. Levine⁴, J. Runo⁵, H. Te⁶, J. Rangaswami⁷, D. Dadhania⁸, D. Axelrod⁹, M. Schnitzler³, H. Xiao¹, B. Kasiske¹⁰, J. Snyder¹⁰, T. Villines¹¹
¹Department of Medicine, Saint Louis Univ, Saint Louis, MO, ²Dartmouth, Lebanon, NH, ³Saint Louis Univ, Saint Louis, MO, ⁴UT Health, San Antonio, TX, ⁵Univ of Wisconsin, Madison, WI, ⁶Univ of Chicago, Chicago, IL, ⁷Einstein Medical Ctr, Philadelphia, PA, ⁸Weill Cornell, New York, NY, ⁹Univ of Iowa, Iowa City, IA, ¹⁰SRTR, Minneapolis, MN, ¹¹Univ of Virginia, Charlottesville, VA
*Purpose: To describe the incidence and mortality implications of pulmonary hypertension (P-HTN) in a large, national cohort of US kidney transplant (KTx) recipients.*Methods: We examined…
2020 American Transplant Congress
Clinical Significance of Late Antibody-Mediated Rejection without Donor Specific Anti-hLA Antibodies
J. Lee¹, E. Kim¹, S. Yang¹, S. Kim¹, B. Lim², H. Choi³, B. Kim⁴, B. Kim⁴, M. Ju⁵, M. Kim¹, S. Kim¹, Y. Kim¹, K. Huh¹
¹Department of Transplantation Surgery, Severance Hospital, Seoul, Korea, Republic of, ²Department of Pathology, Yonsei University College of Medicine, Seoul, Korea, Republic of, ³Department of Internal Medicine, Gangnam Severance Hospital, Seoul, Korea, Republic of, ⁴Department of Internal Medicine, Severance Hospital, Seoul, Korea, Republic of, ⁵Department of Surgery, Gangnam Severance Hospital, Seoul, Korea, Republic of
*Purpose: Late onset antibody-mediated rejection (AMR) is a leading cause of kidney allograft failure. Its diagnosis has been based on a combination of morphologic, immunohistologic…
2020 American Transplant Congress
Comparing Surgical and Urological Complications Over Time in Deceased Donor Kidney Transplantation
A. Mekhaimar, H. Maple, N. Mamode, R. H. Zakri, N. Kessaris
King's College London/Guy's and St Thomas' Hospital, London, United Kingdom
*Purpose: Despite advances in perioperative and post-transplant management over time, complications still occur following deceased donor (DD) kidney transplantation. This study aimed to determine the…
2020 American Transplant Congress
Assessment of Infectious Complications Following ABO-Blood Group Incompatible Renal Transplant
J. Banbury¹, T. Loosier¹, C. Lin², K. Gutierrez¹
¹University of Alabama at Birmingham Hospital, Birmingham, AL, ²Center for Clinical and Translational Science, University of Alabama at Birmingham, Birmingham, AL
*Purpose: In response to the ongoing organ shortage, ABO-incompatible (ABOi) renal transplant (RT) provides an alternative option for patients with end-stage kidney disease. Literature suggests…